TVTX
Travere Therapeutics Inc
52.00$
-2.6%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -162.6% | -0.6% | -1.2% | 4.8% | -15.2% | -33.2% | -21.6% | -11.2% | -170.2% | -192.8% | -101.8% | 7.7% | |
| 19.2% | 13.4% | 12.1% | 11.5% | 11.4% | 11.6% | 12.4% | 9.7% | 18.9% | 26.5% | 18.7% | 12.4% | |
| 56.4% | 25.9% | 21.8% | 17.3% | 12.0% | 12.0% | 11.9% | 22.4% | 34.8% | 30.5% | 15.8% | 9.1% | |
| – | – | – | 29.0% | 27.4% | 31.5% | 59.3% | 17.6% | 38.0% | – | – | – | |
| 43.6% | -11.4% | 4.1% | 2.5% | 6.7% | 1.5% | -13.1% | 61.3% | 0.8% | -17.5% | -27.0% | -2.9% | |
| 14.1% | 7.0% | 8.9% | 9.0% | 12.0% | 8.9% | 60.4% | 18.3% | 25.9% | 28.6% | 43.4% | 11.9% | |
| -132.1% | -80.7% | 7.8% | 29.4% | -123.8% | 11.3% | -30.9% | -104.4% | -29.7% | 38.4% | 42.6% | 5.7% | |
| 332.2% | – | – | – | – | – | – | – | – | – | – | – | |
| -8.0% | -1.0% | – | – | – | – | 1.0% | 1.6% | 24.8% | – | – | – | |
| – | – | – | 152.2% | 143.6% | 59.8% | 52.9% | 79.6% | 86.8% | 0.0% | 0.0% | -14.0% | |
| 338.0% | 100.9% | -4.3% | 3.5% | 141.2% | -1.2% | 64.4% | 175.7% | 107.4% | 150.6% | 59.8% | -6.8% | |
| 43.3% | 19.6% | 2.4% | 37.7% | 2.1% | -23.1% | 11.3% | 61.4% | -95.1% | -2.4% | 0.2% | 7.0% | |
| -176.6% | -7.6% | -10.1% | -4.3% | -27.2% | -42.1% | -82.0% | -29.5% | -196.1% | -221.4% | -145.3% | -4.2% |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.